Skip to main content
. 2018 May 8;2(9):1022–1031. doi: 10.1182/bloodadvances.2017013052

Table 6.

Multivariable analyses for DFS, TRM, and relapse

DFS TRM Relapse
Variable N RR 99% CI P RR 99% CI P RR 99% CI P
Donor group (main effect)
 Parous sibling (ref) 852 1.00 1.00 1.00
 Male URD 1901 1.04 0.91-1.19 .449 1.07 0.88-1.31 .380 1.03 0.87-1.23 .610
Age at transplant, y <.0001 <.0001 <.0001
 25-39 (ref) 669 1.00 1.00 1.00
 40-49 710 1.17 0.98-1.40 .022 1.32 1.01-1.74 .009 1.09 0.86-1.37 .360
 50-59 848 1.39 1.170-1.64 <.0001 1.67 1.29-2.17 <.0001 1.27 1.02-1.58 .006
 60+ 526 1.66 1.37-2.00 <.0001 2.05 1.53-2.75 <.0001 1.53 1.19-1.96 <.0001
Disease <.0001
 AML (ref) 1701 1.00
 ALL 490 0.97 0.77-1.21 .708
 MDS 562 0.62 0.49-0.77 <.0001
Karnofsky score at transplant <.0001
 ≥90 (ref) 1662 1.00 1.00
 <90 917 1.31 1.15-1.48 <.0001 1.59 1.31-1.92 <.0001
 Missing 174 1.10 0.86-1.41 .308 1.11 0.75-1.63 .487
TBI used in conditioning regimen
 TBI ± others (ref) 1277 1.00 1.00
 Non-TBI 1476 0.86 0.76-0.97 .002 0.83 0.69-0.99 .008
Disease status at transplant <.0001 <.0001
 Early (ref) 1509 1.00 1.00
 Intermediate 466 1.06 0.890-1.26 .407 1.12 0.89-1.42 .198
 Advanced 760 1.87 1.63-2.14 <.0001 2.57 2.15-3.06 <.0001
 Missing 18 1.81 0.92-3.56 .023 2.73 1.24-6.02 .001
Year of transplant .005 .002
 2000-2003 (ref) 544 1.00 1.00
 2004-2008 1464 0.96 0.82-1.13 .534 0.85 0.68-1.08 .077
 2009-2012 745 0.82 0.68-0.98 .004 0.68 0.52-0.90 <.001
Time from diagnosis to transplant, mo .0054
 <6 (ref) 1286 1.00
 6-12 702 1.35 1.08-1.68 .0004
 >12 761 1.10 0.88-1.37 .2842
 Missing 4 1.44 0.11-19 .7165